140 related articles for article (PubMed ID: 11561686)
1. Compatibility and stability of the investigational polypeptide marine anticancer agent kahalalide F in infusion devices.
Nuijen B; Bouma M; Manada C; Jimeno JM; Lazaro LL; Bult A; Beijnen JH
Invest New Drugs; 2001; 19(4):273-81. PubMed ID: 11561686
[TBL] [Abstract][Full Text] [Related]
2. Compatibility and stability of aplidine, a novel marine-derived depsipeptide antitumor agent, in infusion devices, and its hemolytic and precipitation potential upon i.v. administration.
Nuijen B; Bouma M; Henrar RE; Manada C; Bult A; Beijnen JH
Anticancer Drugs; 1999 Nov; 10(10):879-87. PubMed ID: 10630355
[TBL] [Abstract][Full Text] [Related]
3. Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F.
Nuijen B; Bouma M; Talsma H; Manada C; Jimeno JM; Lopez-Lazaro L; Bult A; Beijnen JH
Drug Dev Ind Pharm; 2001 Sep; 27(8):767-80. PubMed ID: 11699828
[TBL] [Abstract][Full Text] [Related]
4. In vitro hemolysis and buffer capacity studies with the novel marine anticancer agent kahalalide F and its reconstitution vehicle cremophor EL/ethanol.
Nuijen B; Bouma M; Manada C; Jimeno JM; Bult A; Beijnen JH
PDA J Pharm Sci Technol; 2001; 55(4):223-9. PubMed ID: 11505554
[TBL] [Abstract][Full Text] [Related]
5. Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F.
Sparidans RW; Stokvis E; Jimeno JM; López-Lázaro L; Schellens JH; Beijnen JH
Anticancer Drugs; 2001 Aug; 12(7):575-82. PubMed ID: 11487713
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors.
Pardo B; Paz-Ares L; Tabernero J; Ciruelos E; García M; Salazar R; López A; Blanco M; Nieto A; Jimeno J; Izquierdo MA; Trigo JM
Clin Cancer Res; 2008 Feb; 14(4):1116-23. PubMed ID: 18281545
[TBL] [Abstract][Full Text] [Related]
7. Compatibility and stability of Imexon in infusion devices and its in vitro biocompatibility.
den Brok MW; Nuijen B; Challa EE; Lutz C; Opitz HG; Beijnen JH
Anticancer Drugs; 2005 Aug; 16(7):727-32. PubMed ID: 16027520
[TBL] [Abstract][Full Text] [Related]
8. Stability and compatibility of the investigational polymer-conjugated platinum anticancer agent AP 5280 in infusion systems and its hemolytic potential.
Bouma M; Nuijen B; Stewart DR; Rice JR; Jansen BA; Reedijk J; Bult A; Beijnen JH
Anticancer Drugs; 2002 Oct; 13(9):915-24. PubMed ID: 12394254
[TBL] [Abstract][Full Text] [Related]
9. Compatibility and stability of the novel anticancer agent ES-285 x HCl formulated with 2-hydroxypropyl-beta-cyclodextrin in infusion devices.
Den Brok MW; Nuijen B; García JL; Miranda E; Calvo P; Manada C; Beijnen JH
Pharmazie; 2006 Jan; 61(1):21-4. PubMed ID: 16454201
[TBL] [Abstract][Full Text] [Related]
10. Stability study of fotemustine in PVC infusion bags and sets under various conditions using a stability-indicating high-performance liquid chromatographic assay.
Dine T; Khalfi F; Gressier B; Luyckx M; Brunet C; Ballester L; Goudaliez F; Kablan J; Cazin M; Cazin JC
J Pharm Biomed Anal; 1998 Nov; 18(3):373-81. PubMed ID: 10096832
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer.
Rademaker-Lakhai JM; Horenblas S; Meinhardt W; Stokvis E; de Reijke TM; Jimeno JM; Lopez-Lazaro L; Lopez Martin JA; Beijnen JH; Schellens JH
Clin Cancer Res; 2005 Mar; 11(5):1854-62. PubMed ID: 15756010
[TBL] [Abstract][Full Text] [Related]
12. Stability, compatibility and plasticizer extraction of miconazole injection added to infusion solutions and stored in PVC containers.
Faouzi M el-A ; Dine T; Luyckx M; Brunet C; Mallevais ML; Goudaliez F; Gressier B; Cazin M; Kablan J; Cazin JC
J Pharm Biomed Anal; 1995 Oct; 13(11):1363-72. PubMed ID: 8634354
[TBL] [Abstract][Full Text] [Related]
13. Stability, compatibility and plasticizer extraction of quinine injection added to infusion solutions and stored in polyvinyl chloride (PVC) containers.
Faouzi MA; Khalfi F; Dine T; Luyckx M; Brunet C; Gressier B; Goudaliez F; Cazin M; Kablan J; Belabed A; Cazin JC
J Pharm Biomed Anal; 1999 Dec; 21(5):923-30. PubMed ID: 10703960
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical development, quality control, stability and compatibility of a parenteral lyophilized formulation of the investigational polymer-conjugated platinum antineoplastic agent AP5346.
Van der Schoot SC; Nuijen B; Sood P; Thurmond KB; Stewart DR; Rice JR; Beijnen JH
Pharmazie; 2006 Oct; 61(10):835-44. PubMed ID: 17069422
[TBL] [Abstract][Full Text] [Related]
15. Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers.
Craig SB; Bhatt UH; Patel K
J Pharm Biomed Anal; 1997 Oct; 16(2):199-205. PubMed ID: 9408834
[TBL] [Abstract][Full Text] [Related]
16. Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
Waugh WN; Trissel LA; Stella VJ
Am J Hosp Pharm; 1991 Jul; 48(7):1520-4. PubMed ID: 1679294
[TBL] [Abstract][Full Text] [Related]
17. Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions.
Kaiser J; Krämer I
J Oncol Pharm Pract; 2012 Jun; 18(2):213-21. PubMed ID: 22075005
[TBL] [Abstract][Full Text] [Related]
18. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
19. Leaching of diethylhexyl phthalate from multilayer tubing into etoposide infusion solutions.
Bagel-Boithias S; Sautou-Miranda V; Bourdeaux D; Tramier V; Boyer A; Chopineau J
Am J Health Syst Pharm; 2005 Jan; 62(2):182-8. PubMed ID: 15700892
[TBL] [Abstract][Full Text] [Related]
20. Kahalalides V-Y isolated from a Hawaiian collection of the sacoglossan mollusk Elysia rufescens.
Rao KV; Na MK; Cook JC; Peng J; Matsumoto R; Hamann MT
J Nat Prod; 2008 May; 71(5):772-8. PubMed ID: 18407693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
